Absorbable Tissue Spacer Market Size, Analysis, Share, Research, Business Growth and Forecast to 2029

The global absorbable tissue spacer market reached ~US$ 85 Mn in terms of value in 2018, and is expected to propel at an impressive CAGR of ~10 % during the forecast period.

Surging demand for radiation therapy in the backdrop of rising morbidities due to cancers as compared to other chronic diseases altogether in developed and under-developed economies are surfacing as the cornerstone for the progress of absorbable tissue spacer market, says the FMI study. Furthermore, stringent legal policies will persist to regulate the emission of high-energy rays during radiotherapy treatment and assure patient safety, which is likely to motivate manufacturers to perform clinical studies by consulting with experts.

Increasing prevalence of cancers continues to be a global concern, and elimination of cancerous tissues in an efficient way remains of core interest for oncologists and dosimetrists. The leading participants in absorbable tissue spacers market landscape are focusing on conducting clinical trials to develop spacers that are tailored to specific needs of the target area.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-8507

Hydrogel-based Spacer Remains Preferred among Surgeons

As per the findings of FMI’s research, hydrogel-based absorbable tissue spacers account for ~3/4^th shares of total sales. The report further suggests that the hydrogel-based spacer is rapidly becoming an integral component of prostate cancer radiotherapy and is one of the few absorbable tissue spacers that have received government clearance in most of the countries.

Preview Analysis of Absorbable Tissue Spacer Market is segmented by ( Product Type – Hydrogel-Based Spacer, Biodegradable Hyaluronic Acid Spacer, Biodegradable Balloon Spacer & Crystal-Based Spacer; Application – Radiotherapy & Infection Management; End Use – Hospitals, Ambulatory Surgical Centres & Specialized Clinics;) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 – 2029

Hydrogel-based spacers have high tolerability as the space created between prostate and rectum efficiently lowers the emission concentration on the rectum, significantly reducing irritation of rectum during prostate radiotherapy. Placing hydrogel-based spacers is technically less-complicated, especially for surgeons who are aware of ultrasound-directed transperineal injections. Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scans enable confirmation about proper deployment of spacers. Furthermore, patients undergoing radiation therapy with hydrogel-based spacers are lesser prone to adverse long-term rectal complications and relatively decreased amount of rectal pain during treatment, making hydrogel-based spacer most sought-after among oncologists.

Cancer specialists are constantly shifting towards absorbable tissue spacer to cure different types of cancers. Absorbable tissue spacers, after proper placement, protects the adjacent healthy tissues from strong radiation, resulting in increased concentration of dose delivery at the affected organ, thereby eliminating adverse procedural events. Further, absorbable tissue spacers avoid the need for a second surgery for spacer removal as they gradually dissolve into the tissues.

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-8507

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs